in addition, GSH becomes not just an inhibitor of inflammation but a regulator of innate immunity in a direction that benefits the host (134)
J., Head, A., Scott, G
El tratamiento de la DM tiene como objetivos asegurar al paciente una buena calidad de vida, disminuir el riesgo de complicaciones especficas (retinopata, nefropata, neuropata) y de eventos cardiovasculares (CV) que son su principal causa de mortalidad
Biosimilars could help to solve this problem, but unfortunately for the patients, patents are not expected to expire any soon
Track specific markers including pain levels (using a consistent 0-10 scale), range of motion, visible swelling, and functional capacity
Only the functionalization with A-GSH ligands of 3-PLG-dopa or 3-PLG-ibu elevated significantly the cellular uptake indicating a lesser role in physicochemical properties like charge for these nanocarriers